Skip to main content
. 2023 Apr 3;108(5):927–935. doi: 10.4269/ajtmh.22-0242

Table 4.

Susceptibility profile of Gram-positive cocci isolates from urine samples

Tested antibiotics GPC CNS S. saprophyticus S. aureus S. agalactia E. faecalis
Nb Result Nb Result Nb Result Nb Result Nb Result Nb Result
Penicillins
 Penicillin G 213 36 (16.9%) 157 23 (14.6%) 118 16 (13.6%) 52 9 (17.3%) 4 4 (100%) 0 –
 Oxacillin 209 113 (54.1%) 157 68 (43.3%) 118 56 (47.5%) 52 45 (86.5%) 0 – 0 –
 Amoxicillin 185 184 (99.5%) – – – – – – 101 101 (100%) 83 83 (100%)
Aminoglycosides
 Kanamycin 209 197 (94.3%) 157 146 (93%) 118 115 (97.5%) 52 51 (98.1%) – – – –
 Tobramycin 209 197 (94.3%) 157 146 (93%) 118 115 (97.5%) 52 51 (98.1%) – – – –
 Gentamycin 209 198 (94.7%) 157 146 (93%) 118 115 (97.5%) 52 52 (100%) – – – –
Macrolids
 Tetracyclin 218 166 (76.1%) 157 122 (77.7%) 118 106 (89.8%) 52 43 (82.7%) 9 1 (11.1%) – –
 Erythromycin 267 123 (46.1%) 157 77 (49%) 118 55 (46.6%) 52 38 (73.1%) 9 7 (77.8%) 49 1 (2%)
 Lincomycin 203 189 (93.1%) 153 139 (90.8%) 114 104 (91.2%) 50 50 (100%) – – – –
Fluoroquinolones
 Ofloxacin 209 183 (87.6%) 157 139 (88.5%) 118 111 (94.1%) 52 44 (84.6%) – – – –
Glycopeptides
 Vancomycin 268 265 (98.9%) 157 156 (99.4%) 118 117 (99.2%) 52 52 (100%) 9 9 (100%) 49 48 (98%)
Others
 TMP/SMX 256 189 (73.8%) 157 107 (68.2%) 118 79 (66.9%) 52 48 (92.3%) – – 47 34 (72.3%)
 Rifampicin 210 201 (95.7%) 157 149 (94.9%) 118 115 (97.5%) 52 52 (100%) – – – –
 Nitrofurantoin 253 251 (99.2%) 146 145 (99.3%) 109 108 (99.1%) 49 49 (100%) 9 8 (88.9%) 49 49 (100%)
 Fosfomycin 209 57 (27.3%) 157 6 (3.8%) – – 52 51 (98.1%) – – – –
 Fucidic acid 209 68 (32.5%) 157 22 (14%) – – 52 46 (88.5%) – – – –
 Linezolid 259 254 (98.1%) 149 144 (96.6%) 112 107 (95.5%) 51 51 (100%) 9 9 (100%) 49 49 (100%)

CNS = coagulase-negative staphylococci; GPC = Gram-positive cocci; Nb = number of tested isolates; TMP/SMX = trimethoprim/sulfamethoxazole.